Administrative Core
- Institution
- Beth Israel Deaconess Medical Center, MA
- Principal investigator
- Steven P. Balk
- Funding
- $332K
- Duration
- 2013–2030
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT The Administrative Core (Core A) has fulfilled three major functions during the current grant, and will continue to do so in this renewal. One function is the overall management of the P01, which is the responsibility of the PI, Steven Balk, with an administrator and in consultation with the other PIs. This includes addressing all administrative issues, organizing group meetings, organizing internal and external reviews, and in general facilitating communications and collaborations. The second function of the Core has been to assist the Projects in efforts to ensure that their laboratory studies and findings are physiologically significant, and ultimately to translate their findings into patients. This has been facilitated by close interactions with our clinicians, represented by our internal advisory board. Through previous/ongoing clinical trials and tissue banking efforts at their respective institutions, these clinical investigators have collected (and continue to collect) valuable samples from patients at varying stages of their disease and after varying therapies. In discussions with the Project Leaders, they have provided relevant clinical samples for analysis and have provided further insight into potential biological significance of laboratory findings. The third Core function is to provide statistical support for each of the Project Leaders in their experimental designs. The Specific Aims are 1) Provide administrative support to insure that the goals of the project are achieved, 2) Assist in translating the results from each Project into the clinic, 3) Provide biostatistical support for each Project.
LOADING MOONBASE SCORE
Questions for Beth Israel Deaconess Medical Center
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Beth Israel Deaconess Medical CenterNot yet scored
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer
Steven P. Balk · $396K · 2023–2028
- NIH · Beth Israel Deaconess Medical CenterNot yet scored
Enhancing the Efficacy of Docetaxel in Prostate Cancer
Steven P. Balk · $655K · 2022–2027
- NIH · Beth Israel Deaconess Medical CenterNot yet scored
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
Steven P. Balk · $400K · 2021–2026